Cytogel Pharma, LLC
CIK 1491841 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Cytogel Pharma, LLC.
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Mar 26, 2026 | D/A | 0001213900-26-034790 |
| Dec 23, 2025 | D/A | 0001213900-25-125022 |
| Dec 23, 2025 | D | 0001213900-25-124742 |
| Oct 11, 2024 | D/A | 0001213900-24-087167 |
| Jul 28, 2023 | D | 0001213900-23-060531 |
| Jul 12, 2022 | D | 0001213900-22-038854 |
| May 21, 2021 | D/A | 0001062993-21-004957 |
| Mar 16, 2021 | D/A | 0001062993-21-002745 |
| Mar 23, 2020 | D/A | 0001062993-20-001468 |
| Sep 30, 2019 | D | 0001062993-19-003773 |
| Mar 12, 2019 | D | 0001062993-19-001237 |
| May 31, 2018 | D | 0001062993-18-002449 |
| Jan 7, 2015 | D | 0001062993-15-000038 |
| Mar 20, 2014 | D | 0001062993-14-001514 |
| Jul 12, 2013 | D/A | 0001062993-13-003422 |
| Feb 12, 2013 | D | 0001062993-13-000661 |
| May 17, 2010 | D | 0001062993-10-001628 |